Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D
Substance use disorders provide challenges for development of effective medications. Use of abused substances is likely initiated, sustained and “quit” by complex brain and pharmacological mechanisms that have both genetic and environmental determinants. Medical utilities of prescribed stimulants an...
Main Author: | George R. Uhl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1031283/full |
Similar Items
-
Manzamenones Inhibit T-Cell Protein Tyrosine Phosphatase
by: Jun'ichi Kobayashi, et al.
Published: (2006-02-01) -
A Polydnavirus <i>Protein Tyrosine Phosphatase</i> Negatively Regulates the Host Phenoloxidase Pathway
by: Hong-Shuai Gao, et al.
Published: (2022-12-01) -
Trypanosoma rangeli protein tyrosine phosphatase is associated with the parasite's flagellum
by: Elisa Beatriz Prestes, et al.
Published: (2012-09-01) -
LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain
by: Francisca Cornejo, et al.
Published: (2021-12-01) -
T Cell Protein Tyrosine Phosphatase in Osteoimmunology
by: Ya-nan Wang, et al.
Published: (2021-02-01)